Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HKDC1 | Q2TB90 | 2/20 | 0.43 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 5/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | CDC25A | P30304 | 1/20 | 0.39 |
| ▸ | CDC25B | P30305 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 5/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | ATM | Q13315 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3417111 | 0.77 | HKDC1 (0.56) | HKDC1ERBB2IDO1PTPN1CDC25A | |
| SCHEMBL4062188 | 0.73 | HKDC1 (0.31) | HKDC1IDO1 | |
| SCHEMBL49783 | 0.72 | MAPT (0.50) | HKDC1MAPTKMT2AMEN1MAPK1 | |
| SCHEMBL49737 | 0.72 | ERBB2 (0.62) | HKDC1ERBB2IDO1PTPN1CDC25A | |
| SCHEMBL5920181 | 0.71 | MAPT (0.34) | HKDC1ERBB2MAPTKMT2AKDM4E | |
| SCHEMBL28856262 | 0.69 | ERBB2 (0.59) | HKDC1ERBB2IDO1PTPN1CDC25A | |
| SCHEMBL11025815 | 0.69 | MAPT (0.50) | HKDC1ERBB2IDO1PTPN1CDC25A | |
| SCHEMBL15759639 | 0.68 | MAPT (0.50) | HKDC1ERBB2IDO1PTPN1CDC25A | |
| SCHEMBL9275509 | 0.67 | HKDC1 (0.46) | HKDC1ERBB2IDO1PTPN1CDC25A | |
| SCHEMBL20201393 | 0.67 | MAPT (0.41) | MAPTKMT2AALDH1A1ATMHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 566 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119912606-A | Catalyst suitable for ethylene polymerization reaction and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-118993854-A | Rare earth promoted lignin beta-O-4 model compound oxidation method | 浙江大学衢州研究院 | 2024-11-22 | — | — | CN | claimed |
| US-20220304944-A1 | METHODS FOR REDUCING THC CONTENT IN COMPLEX CANNABINOID MIXTURES IN WHICH THC IS A MINOR COMPONENT | CANOPY GROWTH CORPORATION (CA) | 2022-09-29 | — | — | US | claimed |
| EP-2603598-B1 | COMPOSITIONS COMPRISING A GH61 POLYPEPTIDE HAVING CELLULOLYTIC ENHANCING ACTIVITY AND A QUINONE COMPOUND AND USES THEREOF | NOVOZYMES INC (US) | 2018-04-18 | — | — | EP | claimed |
| US-20180019412-A1 | Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Quinone Compound And Uses Thereof | NOVOZYMES, INC. (US) | 2018-01-18 | — | — | US | claimed |
| US-9752168-B2 | Compositions comprising a polypeptide having cellulolytic enhancing activity and a quinone compound and uses thereof | NOVOZYMES, INC. (US) | 2017-09-05 | — | — | US | claimed |
| US-9663804-B2 | Method of treating polyester textile | NOVOZYMES A/S (DK) | 2017-05-30 | — | — | US | claimed |
| US-20160251686-A1 | Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Quinone Compound And Uses Thereof | NOVOZYMES INC (US) | 2016-09-01 | — | — | US | claimed |
| US-9273335-B2 | Compositions comprising a polypeptide having cellulolytic enhancing activity and a quinone compound and uses thereof | NOVOZYMES, INC. (US) | 2016-03-01 | — | — | US | claimed |
| US-20130164791-A1 | Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Quinone Compound And Uses Thereof | NOVOZYMES, INC. (US) | 2013-06-27 | — | — | US | claimed |
| EP-2603598-A1 | COMPOSITIONS COMPRISING A POLYPEPTIDE HAVING CELLULOLYTIC ENHANCING ACTIVITY AND A QUINONE COMPOUND AND USES THEREOF | Novozymes, Inc. (US) | 2013-06-19 | — | — | EP | claimed |
| WO-2012021394-A1 | COMPOSITIONS COMPRISING A POLYPEPTIDE HAVING CELLULOLYTIC ENHANCING ACTIVITY AND A QUINONE COMPOUND AND USES THEREOF | NOVOZYMES, INC. (US) | 2012-02-16 | — | — | WO | claimed |
| US-12600996-B2 | Carbohydrate binding module variants and hybrid polypeptides comprising same | NOVOZYMES A/S (DK) | 2026-04-14 | — | — | US | disclosed |
| CN-119912606-A | Catalyst suitable for ethylene polymerization reaction and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-05-02 | — | — | CN | disclosed |
| US-20250092434-A1 | CELLULOLYTIC ENZYME COMPOSITIONS AND USES THEREOF | NOVOZYMES, INC. (US) | 2025-03-20 | — | — | US | disclosed |
| US-12195776-B2 | Cellulolytic enzyme compositions and uses thereof | NOVOZYMES, INC. (US) | 2025-01-14 | — | — | US | disclosed |
| US-20100129723-A1 | NON-AQUEOUS ELECTROLYTE FOR PRIMARY BATTERY, AND NON-AQUEOUS ELECTROLYTE PRIMARY BATTERY USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2010-05-27 | — | — | US | disclosed |
| EP-1933404-A1 | NON-AQUEOUS ELECTROLYTE FOR PRIMARY BATTERY, AND NON-AQUEOUS ELECTROLYTE PRIMARY BATTERY USING THE SAME | Mitsubishi Chemical Corporation (JP) | 2008-06-18 | — | — | EP | disclosed |
| US-7241551-B2 | Positive-working resist composition | FUJIFILM CORPORATION (JP) | 2007-07-10 | — | — | US | disclosed |
| US-7241551-B2 | Positive-working resist composition | FUJIFILM CORPORATION (JP) | 2007-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600996-B2 | Carbohydrate binding module variants and hybrid polypeptides comprising same | QPCTL, DNTT, RNGTT | HKDC1 1589/4885ERBB2 4833/4885IDO1 3267/4885 |
| US-20180019412-A1 | Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Quinone Compound And Uses Thereof | PGLS, CEL, PNLIP | HKDC1 1376/4885ERBB2 4571/4885IDO1 1922/4885 |
| US-20220304944-A1 | METHODS FOR REDUCING THC CONTENT IN COMPLEX CANNABINOID MIXTURES IN WHICH THC IS A MINOR COMPONENT | CNR2, CNR1, FAAH | HKDC1 3546/4885ERBB2 586/4885IDO1 1192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.